As of 2026-05-26, the Fair Value of Bio-Gene Technology Ltd (BGT.AX) is -0.04 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.03 AUD, the upside of Bio-Gene Technology Ltd is -242.45%.
With the market price of 0.03 AUD and our fair value calculation, Bio-Gene Technology Ltd (BGT.AX) is not a good investment. Investing in BGT.AX stocks now will result in a potential loss of 242.45%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 5Y Avg | |
| Net income | -2.40 | -2.91 | -3.10 | -2.41 | -2.58 | -2.68 |
| YoY growth | -23.96% | -21.61% | -6.23% | 22.18% | -7.28% | -7.38% |
| Market Cap (mil) | 8.85 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | -7.38% |
| TTM earnings | -2.52 |